ticker stringlengths 1 10 | date timestamp[ns] | client stringlengths 1 80 | client_description stringlengths 2 114 ⌀ | spend float64 0 25.9M | transaction_type stringclasses 7
values | filing_type stringclasses 7
values | lobby_description listlengths 0 34 | issue_codes listlengths 1 34 ⌀ | government_entity_details listlengths 1 725 ⌀ | quarter stringclasses 66
values | effective_date stringlengths 10 10 | termination_date stringlengths 10 10 ⌀ | client_state stringclasses 56
values | client_country stringclasses 40
values | client_id int64 12 10M | government_lobby float64 0 1 ⌀ | performing_own_lobbying float64 0 1 ⌀ | registrant_dt_updated stringlengths 32 32 | registrant_name stringlengths 3 99 | registrant_address stringlengths 32 87 | registrant_id int64 33 401M | registrant_description stringlengths 2 103 ⌀ | registrant_contact_name stringlengths 0 34 | registrant_house_registrant_id float64 12.7k 401M ⌀ | registrant_contact_telephone stringlengths 0 16 | lobbyist_full_names listlengths 1 272 ⌀ | lobbyist_ids listlengths 1 272 ⌀ | previous_goverment_positions listlengths 1 272 ⌀ | lobbyist_new_statuses listlengths 1 272 ⌀ | client_url stringlengths 44 45 | registrant_url stringlengths 45 52 | filing_url stringlengths 88 88 | filing_id stringlengths 36 36 | unique_id stringlengths 46 53 | match stringlengths 1 80 | date_time timestamp[ns] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
45774N10 | 2014-01-15T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2013-Q4 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/6e6616d3-9007-486b-a419-74fdc8f92754/print/ | 6e6616d3-9007-486b-a419-74fdc8f92754 | 6e6616d3-9007-486b-a419-74fdc8f92754_32098_139897 | innophos holdings, inc. | 2014-01-15T14:28:33 |
45774N10 | 2014-04-15T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2014-Q1 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/c088151f-f706-4e21-bd03-834877c3af32/print/ | c088151f-f706-4e21-bd03-834877c3af32 | c088151f-f706-4e21-bd03-834877c3af32_32098_139897 | innophos holdings, inc. | 2014-04-15T18:48:48 |
45774N10 | 2014-07-21T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2014-Q2 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/50cfdf05-dea9-406e-8ce1-ed03811f2645/print/ | 50cfdf05-dea9-406e-8ce1-ed03811f2645 | 50cfdf05-dea9-406e-8ce1-ed03811f2645_32098_139897 | innophos holdings, inc. | 2014-07-21T22:18:52 |
45774N10 | 2014-10-14T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2014-Q3 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/cb5cc671-0e12-4ccb-bce4-b58112c33b02/print/ | cb5cc671-0e12-4ccb-bce4-b58112c33b02 | cb5cc671-0e12-4ccb-bce4-b58112c33b02_32098_139897 | innophos holdings, inc. | 2014-10-14T13:17:59 |
45774N10 | 2015-01-16T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2014-Q4 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/f359abce-1238-442a-b1d7-5337c5015e42/print/ | f359abce-1238-442a-b1d7-5337c5015e42 | f359abce-1238-442a-b1d7-5337c5015e42_32098_139897 | innophos holdings, inc. | 2015-01-16T20:05:27 |
45774N10 | 2015-03-01T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | service_provided | [
"United States foreign policy and trade relations with Morocco."
] | [
"FOR - Foreign Relations"
] | [
"24 - Commerce, Dept of (DOC)",
"16 - Natl Security Council (NSC)",
"1 - SENATE",
"39 - State, Dept of (DOS)",
"12 - White House Office"
] | 2009-Q4 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | [
"STEVEN RICHARDS VALENTINE",
"CRESENCIO S ARCOS",
"KARISHMA SHAH PAGE"
] | [
43785,
41123,
48804
] | [
null,
null,
null
] | [
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/530a4a9d-bb73-4ac8-9ec1-8903ed07389c/print/ | 530a4a9d-bb73-4ac8-9ec1-8903ed07389c | 530a4a9d-bb73-4ac8-9ec1-8903ed07389c_32098_139897 | innophos holdings, inc. | null |
45774N10 | 2015-03-01T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2016-Q4 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/299d79aa-b1dd-4566-b0ec-f052b922f792/print/ | 299d79aa-b1dd-4566-b0ec-f052b922f792 | 299d79aa-b1dd-4566-b0ec-f052b922f792_32098_139897 | innophos holdings, inc. | null |
45774N10 | 2015-04-13T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 10,000 | lobbying_income | service_provided | [
"Environmental Protection Agency review of no-migration petition for well at Geismar, Louisiana plant."
] | [
"ENV - Environment/Superfund"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2015-Q1 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | [
"STEVEN RICHARDS VALENTINE",
"CLIFF ROTHENSTEIN"
] | [
43785,
53051
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/338b7be1-4913-45ee-9b3e-82ad8685fcf0/print/ | 338b7be1-4913-45ee-9b3e-82ad8685fcf0 | 338b7be1-4913-45ee-9b3e-82ad8685fcf0_32098_139897 | innophos holdings, inc. | 2015-04-13T14:30:36 |
45774N10 | 2015-07-20T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2015-Q2 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/3c6dbffc-fd97-419d-9f5b-34da7f890f87/print/ | 3c6dbffc-fd97-419d-9f5b-34da7f890f87 | 3c6dbffc-fd97-419d-9f5b-34da7f890f87_32098_139897 | innophos holdings, inc. | 2015-07-20T23:10:14 |
45774N10 | 2015-10-14T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2015-Q3 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/2e4cfd4d-66f0-4cd7-860f-d4d9cf82f374/print/ | 2e4cfd4d-66f0-4cd7-860f-d4d9cf82f374 | 2e4cfd4d-66f0-4cd7-860f-d4d9cf82f374_32098_139897 | innophos holdings, inc. | 2015-10-14T21:43:01 |
45774N10 | 2016-01-20T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 20,000 | lobbying_income | service_provided | [
"EPA approval of deep well application."
] | [
"ENV - Environment/Superfund"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2015-Q4 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | [
"STEVEN RICHARDS VALENTINE",
"CLIFF ROTHENSTEIN"
] | [
43785,
53051
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/df72faf3-73b8-4cd8-b2ea-eda42b6d9829/print/ | df72faf3-73b8-4cd8-b2ea-eda42b6d9829 | df72faf3-73b8-4cd8-b2ea-eda42b6d9829_32098_139897 | innophos holdings, inc. | 2016-01-20T14:32:01 |
45774N10 | 2016-04-13T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | service_provided | [
"EPA approval of deep well application."
] | [
"ENV - Environment/Superfund"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q1 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | [
"STEVEN RICHARDS VALENTINE",
"CLIFF ROTHENSTEIN"
] | [
43785,
53051
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/b4e183eb-581d-4c01-a84b-1287d55d9e07/print/ | b4e183eb-581d-4c01-a84b-1287d55d9e07 | b4e183eb-581d-4c01-a84b-1287d55d9e07_32098_139897 | innophos holdings, inc. | 2016-04-13T20:47:49 |
45774N10 | 2016-07-20T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2016-Q2 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/f78350e9-751f-4236-8acd-467f63a7cd19/print/ | f78350e9-751f-4236-8acd-467f63a7cd19 | f78350e9-751f-4236-8acd-467f63a7cd19_32098_139897 | innophos holdings, inc. | 2016-07-20T18:37:17 |
45774N10 | 2016-10-18T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2016-Q3 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/72a2e276-0201-4388-8a85-29dde9e181cd/print/ | 72a2e276-0201-4388-8a85-29dde9e181cd | 72a2e276-0201-4388-8a85-29dde9e181cd_32098_139897 | innophos holdings, inc. | 2016-10-18T19:25:00 |
45774N10 | 2017-04-20T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2017-Q1 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/865eab0a-9b2c-4a1b-8da5-cf5ecf77b54e/print/ | 865eab0a-9b2c-4a1b-8da5-cf5ecf77b54e | 865eab0a-9b2c-4a1b-8da5-cf5ecf77b54e_32098_139897 | innophos holdings, inc. | 2017-04-20T13:27:39 |
45774N10 | 2017-07-14T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | retainer | [] | null | null | 2017-Q2 | 2015-03-01 | null | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/d5402d29-b51a-40b9-bcaf-c5b2f78d7a79/print/ | d5402d29-b51a-40b9-bcaf-c5b2f78d7a79 | d5402d29-b51a-40b9-bcaf-c5b2f78d7a79_32098_139897 | innophos holdings, inc. | 2017-07-14T17:07:13 |
45774N10 | 2017-10-12T00:00:00 | innophos holdings, inc. | Producer of phosphate products for food, pharmaceutical and industrial industries. | 5,000 | lobbying_income | terminate_retainer | [] | null | null | 2017-Q3 | 2015-03-01 | 2017-09-30 | NJ | US | 5,126 | 0 | null | 2024-01-24T11:38:27.060076-05:00 | K&L GATES, LLP | 1601 K Street, NW, Washington, DC, 20006, US | 32,098 | Law firm | CAROL MICHAELSEN | 31,355 | +1 202-661-3868 | null | null | null | null | https://lda.senate.gov/api/v1/clients/139897/ | https://lda.senate.gov/api/v1/registrants/32098/ | https://lda.senate.gov/filings/public/filing/9edc6b82-b018-42cb-9a84-f5033fd9c114/print/ | 9edc6b82-b018-42cb-9a84-f5033fd9c114 | 9edc6b82-b018-42cb-9a84-f5033fd9c114_32098_139897 | innophos holdings, inc. | 2017-10-12T20:20:28 |
4641 | 2008-04-18T00:00:00 | altech corporation | null | 20,000 | lobbying_income | modify_termination | [
"HR 1585, S 1547 House and Senate Defense Authorization and House and Senate Defense Appropriations. Funding for army range training upgrades."
] | [
"DEF - Defense"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2008-Q1 | 2007-08-02 | 2007-08-31 | OK | US | 4,531 | 0 | 0 | 2024-01-26T10:21:03.693944-05:00 | STRATEGIC MARKETING INNOVATIONS | 200 Massachusetts Avenue, Suite 510, Washington, DC, 20001, US | 60,550 | Federal relations firm | KENNETH WETZEL, JR. | 35,365 | +1 202-467-5459 | [
"PATRICK PETERSON",
"MICHAEL DEYOUNG"
] | [
1117,
518
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/161089/ | https://lda.senate.gov/api/v1/registrants/60550/ | https://lda.senate.gov/filings/public/filing/d38c6207-8349-4463-b297-01190829b2f7/print/ | d38c6207-8349-4463-b297-01190829b2f7 | d38c6207-8349-4463-b297-01190829b2f7_60550_161089 | altech corporation | 2008-04-18T20:28:40 |
47214710 | 2012-03-01T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nPrescription drug abuse;\nSenate HELP Committee's Innovation Working Group;"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/eb106bae-65fd-4211-bc75-565bb773f1b8/print/ | eb106bae-65fd-4211-bc75-565bb773f1b8 | eb106bae-65fd-4211-bc75-565bb773f1b8_72111_165792 | jazz pharmaceuticals, inc. | null |
47214710 | 2012-04-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 5,000 | lobbying_income | retainer | [] | null | null | 2012-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | null | null | null | null | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/0f61d03e-2354-4b59-b528-1dfe8f8992aa/print/ | 0f61d03e-2354-4b59-b528-1dfe8f8992aa | 0f61d03e-2354-4b59-b528-1dfe8f8992aa_72111_165792 | jazz pharmaceuticals, inc. | 2012-04-20T23:38:55 |
47214710 | 2012-07-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language;\nH.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language",
"S. 3187 Food and Drug Administratio... | [
"PHA - Pharmacy",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2012-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL",
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL"
] | [
48260,
23462,
10838,
48260,
23462,
10838
] | [
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/3ecb3ea4-4f0d-45c6-b051-e2791c818abc/print/ | 3ecb3ea4-4f0d-45c6-b051-e2791c818abc | 3ecb3ea4-4f0d-45c6-b051-e2791c818abc_72111_165792 | jazz pharmaceuticals, inc. | 2012-07-20T23:40:46 |
47214710 | 2012-10-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"S. 3187 Food and Drug Administration Safety and Innovation Act; \nH.R. 5651 Food and Drug Administration Reform Act of 2012"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2012-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL"
] | [
48260,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/0104bce9-d67a-4224-b7d2-53a54eddb8ee/print/ | 0104bce9-d67a-4224-b7d2-53a54eddb8ee | 0104bce9-d67a-4224-b7d2-53a54eddb8ee_72111_165792 | jazz pharmaceuticals, inc. | 2012-10-21T23:16:27 |
47214710 | 2013-01-23T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of The Food and Drug Administration Safety and Innovation Act (PL 112-144); \ndrug safety issues"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2012-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL"
] | [
48260,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/229448f2-640e-4034-8ebb-95ae7dec62c0/print/ | 229448f2-640e-4034-8ebb-95ae7dec62c0 | 229448f2-640e-4034-8ebb-95ae7dec62c0_72111_165792 | jazz pharmaceuticals, inc. | 2013-01-23T00:53:44 |
47214710 | 2013-04-22T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of The Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2013-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL"
] | [
48260,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/4924c9a7-1b61-44d7-b68e-acd9098d58a1/print/ | 4924c9a7-1b61-44d7-b68e-acd9098d58a1 | 4924c9a7-1b61-44d7-b68e-acd9098d58a1_72111_165792 | jazz pharmaceuticals, inc. | 2013-04-22T23:26:47 |
47214710 | 2013-07-22T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2013-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL"
] | [
48260,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/2b624f04-3590-4a87-95a3-559f92808430/print/ | 2b624f04-3590-4a87-95a3-559f92808430 | 2b624f04-3590-4a87-95a3-559f92808430_72111_165792 | jazz pharmaceuticals, inc. | 2013-07-23T02:31:17 |
47214710 | 2013-10-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2013-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER",
"AMY TEJRAL"
] | [
48260,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/26e443e2-a691-40fa-b064-5c654d2e9796/print/ | 26e443e2-a691-40fa-b064-5c654d2e9796 | 26e443e2-a691-40fa-b064-5c654d2e9796_72111_165792 | jazz pharmaceuticals, inc. | 2013-10-22T00:13:17 |
47214710 | 2014-01-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2013-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER"
] | [
48260,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/5881a585-ba2a-496a-87a0-b6e9e8bac478/print/ | 5881a585-ba2a-496a-87a0-b6e9e8bac478 | 5881a585-ba2a-496a-87a0-b6e9e8bac478_72111_165792 | jazz pharmaceuticals, inc. | 2014-01-21T19:33:33 |
47214710 | 2014-04-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues"
] | [
"HCR - Health Issues"
] | [
"11 - Executive Office of the President (EOP)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2014-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER"
] | [
48260,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/400ff958-2e0b-43bf-b44f-e9f7ab8d3dd6/print/ | 400ff958-2e0b-43bf-b44f-e9f7ab8d3dd6 | 400ff958-2e0b-43bf-b44f-e9f7ab8d3dd6_72111_165792 | jazz pharmaceuticals, inc. | 2014-04-21T18:40:24 |
47214710 | 2014-07-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues;\nCampus sexual assault initiative"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2014-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER"
] | [
48260,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/fb5f5884-751a-4d88-9872-742f5e4f8741/print/ | fb5f5884-751a-4d88-9872-742f5e4f8741 | fb5f5884-751a-4d88-9872-742f5e4f8741_72111_165792 | jazz pharmaceuticals, inc. | 2014-07-20T15:38:31 |
47214710 | 2014-10-18T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues;\nCampus sexual assault initiative"
] | [
"HCR - Health Issues"
] | [
"1 - SENATE"
] | 2014-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER"
] | [
48260,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/99009db1-3207-4f4a-89f9-0ad591370b65/print/ | 99009db1-3207-4f4a-89f9-0ad591370b65 | 99009db1-3207-4f4a-89f9-0ad591370b65_72111_165792 | jazz pharmaceuticals, inc. | 2014-10-18T19:22:35 |
47214710 | 2015-01-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nCampus sexual assault initiative"
] | [
"HCR - Health Issues"
] | [
"1 - SENATE"
] | 2014-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER"
] | [
48260,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/543f4778-c550-4d8d-86c5-bc7b6a8ef5aa/print/ | 543f4778-c550-4d8d-86c5-bc7b6a8ef5aa | 543f4778-c550-4d8d-86c5-bc7b6a8ef5aa_72111_165792 | jazz pharmaceuticals, inc. | 2015-01-21T01:39:39 |
47214710 | 2015-04-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\ncampus sexual assault initiative"
] | [
"HCR - Health Issues"
] | [
"1 - SENATE"
] | 2015-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"ELIZABETH MACDONALD BARNETT",
"TRACY SPICER"
] | [
48260,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/18a60aa0-6caf-4458-b4b1-a7bf82522079/print/ | 18a60aa0-6caf-4458-b4b1-a7bf82522079 | 18a60aa0-6caf-4458-b4b1-a7bf82522079_72111_165792 | jazz pharmaceuticals, inc. | 2015-04-20T18:49:16 |
47214710 | 2015-07-17T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\ncampus sexual assault initiative;\nH.R. 6, 21st Century Cures",
"H.R. 9, Innovation Act;\nS. 1137, PATENT Act"
] | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2015-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER",
"AMY TEJRAL"
] | [
23462,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/1e1e62d0-5c88-43a9-87bc-d8fa1e7ba8e5/print/ | 1e1e62d0-5c88-43a9-87bc-d8fa1e7ba8e5 | 1e1e62d0-5c88-43a9-87bc-d8fa1e7ba8e5_72111_165792 | jazz pharmaceuticals, inc. | 2015-07-17T17:36:42 |
47214710 | 2015-10-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"H.R. 9, Innovation Act;\nS. 1137, PATENT Act",
"implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\nH.R. 6, 21st Century Cures;\nprescription drug abuse"
] | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues"
] | [
"1 - SENATE",
"1 - SENATE"
] | 2015-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"AMY TEJRAL",
"TRACY SPICER"
] | [
23462,
10838,
23462
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/b8d84a95-91f1-4e82-b1d7-f9a469931a7b/print/ | b8d84a95-91f1-4e82-b1d7-f9a469931a7b | b8d84a95-91f1-4e82-b1d7-f9a469931a7b_72111_165792 | jazz pharmaceuticals, inc. | 2015-10-20T19:51:43 |
47214710 | 2016-01-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\nprescription drug abuse;\nSenate HELP Committee's Innovation Working Group;",
"H.R. 9, Innovation Act;\nS. 1137, PATENT Act;\nS. 779, Fair Access to Science & Technology Research Act of 2015"
] | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2015-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER",
"AMY TEJRAL"
] | [
23462,
23462,
10838
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/bf8e3bbc-97e7-4f53-84a2-f89fe67fdf68/print/ | bf8e3bbc-97e7-4f53-84a2-f89fe67fdf68 | bf8e3bbc-97e7-4f53-84a2-f89fe67fdf68_72111_165792 | jazz pharmaceuticals, inc. | 2016-01-20T15:41:01 |
47214710 | 2016-07-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES Act of 2016)",
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nPrescription drug abuse;"
] | [
"PHA - Pharmacy",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/b9538182-15e4-4abf-839c-6ae8f97c785b/print/ | b9538182-15e4-4abf-839c-6ae8f97c785b | b9538182-15e4-4abf-839c-6ae8f97c785b_72111_165792 | jazz pharmaceuticals, inc. | 2016-07-19T18:17:27 |
47214710 | 2016-10-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nPrescription drug abuse;\nH.R. 6, 21st Century Cures Act;\nH.R. 2841, FAST Generics Act",
"S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES Act of 2016)"
] | [
"HCR - Health Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/f0ee6021-0db7-4d42-b6e4-7af3d9d188af/print/ | f0ee6021-0db7-4d42-b6e4-7af3d9d188af | f0ee6021-0db7-4d42-b6e4-7af3d9d188af_72111_165792 | jazz pharmaceuticals, inc. | 2016-10-20T17:40:26 |
47214710 | 2017-04-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (P.L. 112-144);\nDrug safety issues;\nPrescription drug abuse;\nReauthorization of FDA Prescription Drug User Fee Act (PDUFA) IV;\nH.R. 749, Lower Drug Costs Through Competition Act",
"Creating and Restoring Equal Access to Equivalent Sampl... | [
"HCR - Health Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/8012d738-0a74-4e88-ab39-5d1e6f095518/print/ | 8012d738-0a74-4e88-ab39-5d1e6f095518 | 8012d738-0a74-4e88-ab39-5d1e6f095518_72111_165792 | jazz pharmaceuticals, inc. | 2017-04-20T18:36:15 |
47214710 | 2017-07-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Implementation of Food and Drug Administration Safety and Innovation Act (P.L. 112-144);\nDrug safety issues;\nPrescription drug abuse;\nReauthorization of FDA Prescription Drug User Fee Act (PDUFA) VI;\nH.R. 749, Lower Drug Costs Through Competition Act",
"S. 974, Creating and Restoring Equal Access to Equivale... | [
"HCR - Health Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/b1f5e704-50cd-4740-901e-a3d798fb6de1/print/ | b1f5e704-50cd-4740-901e-a3d798fb6de1 | b1f5e704-50cd-4740-901e-a3d798fb6de1_72111_165792 | jazz pharmaceuticals, inc. | 2017-07-19T15:01:06 |
47214710 | 2017-10-17T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017);\nH.R. 2051, FAST Generics Act",
"Drug safety issues;\nPrescription drug abuse;\nReauthorization of FDA Prescription Drug User Fee Act (PDUFA) VI;\nH.R. 749, Lower Drug Costs Through Competition Act;\nCH... | [
"PHA - Pharmacy",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/24dfea5f-8918-464e-910f-2b1d83b8bdab/print/ | 24dfea5f-8918-464e-910f-2b1d83b8bdab | 24dfea5f-8918-464e-910f-2b1d83b8bdab_72111_165792 | jazz pharmaceuticals, inc. | 2017-10-17T16:09:22 |
47214710 | 2018-01-22T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Drug safety issues;\nPrescription drug abuse;\nH.R. 749, Lower Drug Costs Through Competition Act;\nCHIP reauthorization;\nMedicare extenders negotiations",
"H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017);\nH.R. 2051, FAST Generics Act"
] | [
"HCR - Health Issues",
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2017-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/e1bcc62f-e995-48db-ad05-8f2e068e0623/print/ | e1bcc62f-e995-48db-ad05-8f2e068e0623 | e1bcc62f-e995-48db-ad05-8f2e068e0623_72111_165792 | jazz pharmaceuticals, inc. | 2018-01-22T22:05:08 |
47214710 | 2018-04-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"PL 114-255, 21st Century Cures Act, implementation\nH.R. 4784, Lower Drug Costs Through Competition Act\nS. 974/H.R. 2212, CREATES Act of 2015\nH.R. 2051, FAST Generics\nDrug safety issues\nPrescription drug abuse \nH.R. 1892/PL 115-123, Bipartisan Budget Act of 2018\nH.R. 1625/PL 115-141, Consolidated Appropriat... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/04c848a7-c150-4d7f-9741-4fe45c38ca42/print/ | 04c848a7-c150-4d7f-9741-4fe45c38ca42 | 04c848a7-c150-4d7f-9741-4fe45c38ca42_72111_165792 | jazz pharmaceuticals, inc. | 2018-04-20T01:18:24 |
47214710 | 2018-07-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"PL 114-255, 21st Century Cures Act, implementation; \n\nH.R. 4784, Lower Drug Costs Through Competition Act; \n\nS. 974/H.R. 2212, CREATES Act of 2015; \n\nH.R. 2051, FAST Generics; \n\nDrug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Dis... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/b3f52912-26f2-40b6-9108-189663a1733b/print/ | b3f52912-26f2-40b6-9108-189663a1733b | b3f52912-26f2-40b6-9108-189663a1733b_72111_165792 | jazz pharmaceuticals, inc. | 2018-07-19T17:50:44 |
47214710 | 2018-10-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"PL 114-255, 21st Century Cures Act, implementation; \n\nH.R. 4784, Lower Drug Costs Through Competition Act; \n\nS. 974/H.R. 2212, CREATES Act of 2015; \n\nH.R. 2051, FAST Generics; \n\nDrug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Dis... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/ce91e45c-fc28-4319-8966-07952549b4df/print/ | ce91e45c-fc28-4319-8966-07952549b4df | ce91e45c-fc28-4319-8966-07952549b4df_72111_165792 | jazz pharmaceuticals, inc. | 2018-10-19T14:48:55 |
47214710 | 2019-01-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"PL 114-255, 21st Century Cures Act, implementation; \n\nH.R. 4784, Lower Drug Costs Through Competition Act; \n\nS. 974/H.R. 2212, CREATES Act of 2015; \n\nH.R. 2051, FAST Generics; \n\nDrug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Dis... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2018-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/858270fc-aca0-450a-8c23-9f167a5cfbdf/print/ | 858270fc-aca0-450a-8c23-9f167a5cfbdf | 858270fc-aca0-450a-8c23-9f167a5cfbdf_72111_165792 | jazz pharmaceuticals, inc. | 2019-01-21T19:43:27 |
47214710 | 2019-04-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 60,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 965/ S. 340, CREATES Act of 2019"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/c25621d1-6324-4291-82f5-3f0d8dafc924/print/ | c25621d1-6324-4291-82f5-3f0d8dafc924 | c25621d1-6324-4291-82f5-3f0d8dafc924_72111_165792 | jazz pharmaceuticals, inc. | 2019-04-19T16:52:17 |
47214710 | 2019-07-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 0 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019"... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/41600c3f-3ada-40e7-acbe-1ac76acc5e08/print/ | 41600c3f-3ada-40e7-acbe-1ac76acc5e08 | 41600c3f-3ada-40e7-acbe-1ac76acc5e08_72111_165792 | jazz pharmaceuticals, inc. | 2019-07-19T22:15:35 |
47214710 | 2019-10-17T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019"... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/15220ed4-fa34-4b57-8c48-946d0ce6c060/print/ | 15220ed4-fa34-4b57-8c48-946d0ce6c060 | 15220ed4-fa34-4b57-8c48-946d0ce6c060_72111_165792 | jazz pharmaceuticals, inc. | 2019-10-17T23:28:44 |
47214710 | 2019-10-17T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | modify_service | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019"... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/5f116c4c-8762-4dc6-9d38-5548abd9fae0/print/ | 5f116c4c-8762-4dc6-9d38-5548abd9fae0 | 5f116c4c-8762-4dc6-9d38-5548abd9fae0_72111_165792 | jazz pharmaceuticals, inc. | 2019-10-17T23:31:46 |
47214710 | 2020-01-18T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/28c140ad-08f0-42ef-87fd-6fb1fc4b3a09/print/ | 28c140ad-08f0-42ef-87fd-6fb1fc4b3a09 | 28c140ad-08f0-42ef-87fd-6fb1fc4b3a09_72111_165792 | jazz pharmaceuticals, inc. | 2020-01-18T15:46:45 |
47214710 | 2020-04-17T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/9654df45-a70f-4945-bc6a-cbef89b3bd92/print/ | 9654df45-a70f-4945-bc6a-cbef89b3bd92 | 9654df45-a70f-4945-bc6a-cbef89b3bd92_72111_165792 | jazz pharmaceuticals, inc. | 2020-04-17T18:21:22 |
47214710 | 2020-07-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/5ab8f169-a2b6-4399-b1af-f7d5cedf380e/print/ | 5ab8f169-a2b6-4399-b1af-f7d5cedf380e | 5ab8f169-a2b6-4399-b1af-f7d5cedf380e_72111_165792 | jazz pharmaceuticals, inc. | 2020-07-20T22:20:20 |
47214710 | 2020-10-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/9fe095a6-2b78-4ecc-ba04-8851b5b29108/print/ | 9fe095a6-2b78-4ecc-ba04-8851b5b29108 | 9fe095a6-2b78-4ecc-ba04-8851b5b29108_72111_165792 | jazz pharmaceuticals, inc. | 2020-10-20T21:38:33 |
47214710 | 2021-01-21T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2020-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/5c2ecf4e-4d34-4510-9729-a8d0a6f21fe7/print/ | 5c2ecf4e-4d34-4510-9729-a8d0a6f21fe7 | 5c2ecf4e-4d34-4510-9729-a8d0a6f21fe7_72111_165792 | jazz pharmaceuticals, inc. | 2021-01-21T18:24:23 |
47214710 | 2021-04-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nContinue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress ; \n\nContinue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; \... | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/d0d8ad37-bec6-402e-a2a4-0ce810a713d5/print/ | d0d8ad37-bec6-402e-a2a4-0ce810a713d5 | d0d8ad37-bec6-402e-a2a4-0ce810a713d5_72111_165792 | jazz pharmaceuticals, inc. | 2021-04-20T16:16:23 |
47214710 | 2021-07-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nMonitor drug pricing legislation; \n\nContinue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; \n\nContinue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; \n\nContinue monitoring of Elij... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/23ff0bff-bfa2-45db-b628-c08bbf10e694/print/ | 23ff0bff-bfa2-45db-b628-c08bbf10e694 | 23ff0bff-bfa2-45db-b628-c08bbf10e694_72111_165792 | jazz pharmaceuticals, inc. | 2021-07-20T20:52:54 |
47214710 | 2021-07-20T00:00:00 | jazz pharmaceuticals, inc. | null | 160,000 | a | service_provided | [
"Drug pricing"
] | [
"PHA - Pharmacy"
] | [
"1 - SENATE"
] | 2021-Q2 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"VIRGINIA MCMILLIN (Special Assistant to the President (9/2018-12/2020); Health Policy Advisor, Senate Committee on HELP (1/2018-9/2019); Staff, Senate Committee on HELP (5/2012-1/2018))"
] | [
100657
] | [
"Special Assistant to the President (9/2018-12/2020); Health Policy Advisor, Senate Committee on HELP (1/2018-9/2019); Staff, Senate Committee on HELP (5/2012-1/2018)"
] | [
true
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/8dea1b82-f1d1-45ba-964d-a94c6fc6744e/print/ | 8dea1b82-f1d1-45ba-964d-a94c6fc6744e | 8dea1b82-f1d1-45ba-964d-a94c6fc6744e_401106071_210180 | jazz pharmaceuticals, inc. | 2021-07-20T22:34:46 |
47214710 | 2021-10-20T00:00:00 | jazz pharmaceuticals, inc. | null | 160,000 | a | service_provided | [
"HR 3 - Drug pricing"
] | [
"PHA - Pharmacy"
] | [
"1 - SENATE"
] | 2021-Q3 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"VIRGINIA MCMILLIN"
] | [
100657
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/aa952e75-7c49-401b-bb50-40203d6847bd/print/ | aa952e75-7c49-401b-bb50-40203d6847bd | aa952e75-7c49-401b-bb50-40203d6847bd_401106071_210180 | jazz pharmaceuticals, inc. | 2021-10-20T16:53:00 |
47214710 | 2021-10-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; \n\nMonitor drug pricing legislation; \n\nContinue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; \n\nContinue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; \n\nContinue monitoring of Elij... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/b30cb904-32e2-4df1-8e1e-a5b059ddd248/print/ | b30cb904-32e2-4df1-8e1e-a5b059ddd248 | b30cb904-32e2-4df1-8e1e-a5b059ddd248_72111_165792 | jazz pharmaceuticals, inc. | 2021-10-20T22:05:03 |
47214710 | 2022-01-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues;\n\nMonitor drug pricing legislation;\n\nContinued monitoring drug pricing legislation, including S. 1435, Affordable Prescriptions for Patients Act; H.R. 2873, Affordable Prescriptions for Patients Through Promoting Competition Act; H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription ... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2021-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/216acf8f-b791-49a1-8d5c-e29a6eb7052d/print/ | 216acf8f-b791-49a1-8d5c-e29a6eb7052d | 216acf8f-b791-49a1-8d5c-e29a6eb7052d_72111_165792 | jazz pharmaceuticals, inc. | 2022-01-19T22:40:42 |
47214710 | 2022-01-20T00:00:00 | jazz pharmaceuticals, inc. | null | 90,000 | direct_lobbying_expense | service_provided | [
"HR 3 - Drug pricing Reform"
] | [
"PHA - Pharmacy"
] | [
"1 - SENATE"
] | 2021-Q4 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"VIRGINIA MCMILLIN"
] | [
100657
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/6ed350d1-5c6b-4721-8729-f1eab5c0eb64/print/ | 6ed350d1-5c6b-4721-8729-f1eab5c0eb64 | 6ed350d1-5c6b-4721-8729-f1eab5c0eb64_401106071_210180 | jazz pharmaceuticals, inc. | 2022-01-20T14:38:50 |
47214710 | 2022-04-20T00:00:00 | jazz pharmaceuticals, inc. | null | 460,000 | direct_lobbying_expense | modify_service | [
"H.R.1996 - SAFE Banking Act of 2021 Cannabis Administration & Opportunity Act Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement. FDA regulation of cannabis-de... | [
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q1 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"VIRGINIA MCMILLIN",
"KARAS GROSS (FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08))"
] | [
100657,
139471
] | [
null,
"FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08)"
] | [
false,
true
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/4a90d4d2-7e5c-41ad-9c95-ff695f25e5bb/print/ | 4a90d4d2-7e5c-41ad-9c95-ff695f25e5bb | 4a90d4d2-7e5c-41ad-9c95-ff695f25e5bb_401106071_210180 | jazz pharmaceuticals, inc. | 2022-04-20T16:50:10 |
47214710 | 2022-04-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; Monitor drug pricing legislation; H.R. 5376, Build Back Better Act; Monitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug ref... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | null | 2022-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/480498a1-3a3a-4d61-b07f-a39ea9c98f27/print/ | 480498a1-3a3a-4d61-b07f-a39ea9c98f27 | 480498a1-3a3a-4d61-b07f-a39ea9c98f27_72111_165792 | jazz pharmaceuticals, inc. | 2022-04-20T22:57:29 |
47214710 | 2022-07-20T00:00:00 | jazz pharmaceuticals, inc. | null | 530,000 | direct_lobbying_expense | service_provided | [
"H.R.1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement"
] | [
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q2 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"VIRGINIA MCMILLIN",
"KARAS GROSS"
] | [
100657,
139471
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/5bda1d50-dc02-40d2-a619-8d514436a55d/print/ | 5bda1d50-dc02-40d2-a619-8d514436a55d | 5bda1d50-dc02-40d2-a619-8d514436a55d_401106071_210180 | jazz pharmaceuticals, inc. | 2022-07-20T15:57:49 |
47214710 | 2022-07-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; Monitor drug pricing legislation; H.R. 5376, Build Back Better Act; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug ref... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"1 - SENATE"
] | 2022-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/96e5ffb9-24c5-4bdf-a453-6781e7e282b5/print/ | 96e5ffb9-24c5-4bdf-a453-6781e7e282b5 | 96e5ffb9-24c5-4bdf-a453-6781e7e282b5_72111_165792 | jazz pharmaceuticals, inc. | 2022-07-20T19:17:52 |
47214710 | 2022-10-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety issues; Monitor drug pricing legislation; Issues related to FDA user fee reauthorization bills ( H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval, reimportation, and orpha... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"1 - SENATE"
] | 2022-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/4b6922dc-d588-44fd-bf53-5ed2afb7c394/print/ | 4b6922dc-d588-44fd-bf53-5ed2afb7c394 | 4b6922dc-d588-44fd-bf53-5ed2afb7c394_72111_165792 | jazz pharmaceuticals, inc. | 2022-10-20T14:29:26 |
47214710 | 2022-10-20T00:00:00 | jazz pharmaceuticals, inc. | null | 490,000 | direct_lobbying_expense | service_provided | [
"H.R. 1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement FDA regulation of cannabis derived products"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q3 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"KARAS GROSS",
"VIRGINIA MCMILLIN"
] | [
139471,
100657
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/93b47f37-b7cc-4a3a-9643-cf1fd6bd8e89/print/ | 93b47f37-b7cc-4a3a-9643-cf1fd6bd8e89 | 93b47f37-b7cc-4a3a-9643-cf1fd6bd8e89_401106071_210180 | jazz pharmaceuticals, inc. | 2022-10-20T21:27:18 |
47214710 | 2023-01-19T00:00:00 | jazz pharmaceuticals, inc. | null | 640,000 | direct_lobbying_expense | service_provided | [
"Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q4 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"KARAS GROSS"
] | [
139471
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/c29b07f6-5e4b-4b78-b472-195d2453835a/print/ | c29b07f6-5e4b-4b78-b472-195d2453835a | c29b07f6-5e4b-4b78-b472-195d2453835a_401106071_210180 | jazz pharmaceuticals, inc. | 2023-01-19T22:45:03 |
47214710 | 2023-01-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Drug safety, prescription drug abuse, drug pricing; Inflation Reduction Act of 2022 (PL 117-169); S. 4348, FDA Safety and Landmark Advancements Act; H.R. 7667, Food and Drug Amendments of 2022 H.R. 2617, Consolidated Appropriations Act, 2023"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2022-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER"
] | [
23462
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/5e8bd077-4371-40d5-9a55-e056f2fbe564/print/ | 5e8bd077-4371-40d5-9a55-e056f2fbe564 | 5e8bd077-4371-40d5-9a55-e056f2fbe564_72111_165792 | jazz pharmaceuticals, inc. | 2023-01-20T19:15:13 |
47214710 | 2023-04-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)",
"Drug safety, prescription drug abuse, drug pricing"
] | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/4371057e-a36d-4ba4-9283-90d5ac171ede/print/ | 4371057e-a36d-4ba4-9283-90d5ac171ede | 4371057e-a36d-4ba4-9283-90d5ac171ede_72111_165792 | jazz pharmaceuticals, inc. | 2023-04-20T18:19:20 |
47214710 | 2023-04-20T00:00:00 | jazz pharmaceuticals, inc. | null | 630,000 | direct_lobbying_expense | service_provided | [
"Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation and enforcement Drug safety, prescription drug abuse and drug pricing"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q1 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"KARAS GROSS",
"VIRGINIA MCMILLIN"
] | [
139471,
100657
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/416f2910-eb22-44a2-9205-3ed6d712c8ce/print/ | 416f2910-eb22-44a2-9205-3ed6d712c8ce | 416f2910-eb22-44a2-9205-3ed6d712c8ce_401106071_210180 | jazz pharmaceuticals, inc. | 2023-04-20T20:52:10 |
47214710 | 2023-07-19T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)",
"Drug safety, prescription drug abuse, value of prescription drugs"
] | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q2 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/9f81a6fd-87c6-43e2-adff-d2339e1b962b/print/ | 9f81a6fd-87c6-43e2-adff-d2339e1b962b | 9f81a6fd-87c6-43e2-adff-d2339e1b962b_72111_165792 | jazz pharmaceuticals, inc. | 2023-07-19T21:36:27 |
47214710 | 2023-07-20T00:00:00 | jazz pharmaceuticals, inc. | null | 640,000 | direct_lobbying_expense | service_provided | [
"Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation/enforcement Drug safety, prescription drug abuse and drug pricing SAFE Banking Act 2023"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q2 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"MARK BOLTON",
"VIRGINIA MCMILLIN",
"KARAS GROSS"
] | [
143458,
100657,
139471
] | [
null,
null,
null
] | [
true,
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/a9db2268-51a7-4c88-bf78-9cbe80a129d2/print/ | a9db2268-51a7-4c88-bf78-9cbe80a129d2 | a9db2268-51a7-4c88-bf78-9cbe80a129d2_401106071_210180 | jazz pharmaceuticals, inc. | 2023-07-20T19:47:37 |
47214710 | 2023-10-19T00:00:00 | jazz pharmaceuticals, inc. | null | 640,000 | direct_lobbying_expense | service_provided | [
"Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q3 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"MARK BOLTON",
"VIRGINIA MCMILLIN",
"KARAS GROSS"
] | [
143458,
100657,
139471
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/f5367ec9-a2f4-4fff-8ffa-c2080a303dc6/print/ | f5367ec9-a2f4-4fff-8ffa-c2080a303dc6 | f5367ec9-a2f4-4fff-8ffa-c2080a303dc6_401106071_210180 | jazz pharmaceuticals, inc. | 2023-10-19T22:39:16 |
47214710 | 2023-10-20T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)",
"Drug safety, prescription drug abuse, value of prescription drugs; Issues related to FDA oversight of CBD"
] | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2023-Q3 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/3a0d24c3-143e-49a4-8054-c4af0f0b96d5/print/ | 3a0d24c3-143e-49a4-8054-c4af0f0b96d5 | 3a0d24c3-143e-49a4-8054-c4af0f0b96d5_72111_165792 | jazz pharmaceuticals, inc. | 2023-10-20T14:27:08 |
47214710 | 2024-01-22T00:00:00 | jazz pharmaceuticals, inc. | null | 0 | direct_lobbying_expense | service_provided | [
"Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"71 - Natl Credit Union Administration (NCUA)",
"1 - SENATE"
] | 2023-Q4 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"MARK BOLTON",
"VIRGINIA MCMILLIN",
"KARAS GROSS"
] | [
143458,
100657,
139471
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/49ee4e2c-1f00-45e0-9492-180bf8d20a0b/print/ | 49ee4e2c-1f00-45e0-9492-180bf8d20a0b | 49ee4e2c-1f00-45e0-9492-180bf8d20a0b_401106071_210180 | jazz pharmaceuticals, inc. | 2024-01-22T19:54:37 |
47214710 | 2024-01-22T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 80,000 | lobbying_income | service_provided | [
"Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)",
"Drug safety, prescription drug abuse, value of prescription drugs; Issues related to FDA oversight of CBD; Expiring healthcare extenders"
] | [
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"1 - SENATE"
] | 2023-Q4 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-01-30T15:01:29.953318-05:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462
] | [
null,
null
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/23dab646-731d-4fd6-9ba0-38392540412f/print/ | 23dab646-731d-4fd6-9ba0-38392540412f | 23dab646-731d-4fd6-9ba0-38392540412f_72111_165792 | jazz pharmaceuticals, inc. | 2024-01-22T21:45:10 |
47214710 | 2024-04-19T00:00:00 | jazz pharmaceuticals, inc. | null | 690,000 | direct_lobbying_expense | modify_service | [
"Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023"
] | [
"PHA - Pharmacy"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"71 - Natl Credit Union Administration (NCUA)",
"1 - SENATE"
] | 2023-Q4 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-01-30T10:20:24.911943-05:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"MARK BOLTON",
"VIRGINIA MCMILLIN",
"KARAS GROSS"
] | [
143458,
100657,
139471
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/7397d2a5-1f45-48bb-b05f-fa33f473a731/print/ | 7397d2a5-1f45-48bb-b05f-fa33f473a731 | 7397d2a5-1f45-48bb-b05f-fa33f473a731_401106071_210180 | jazz pharmaceuticals, inc. | 2024-04-19T23:21:48 |
47214710 | 2024-04-19T00:00:00 | jazz pharmaceuticals, inc. | null | 0 | direct_lobbying_expense | service_provided | [
"Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies"
] | [
"PHA - Pharmacy"
] | [
"135 - Food & Drug Administration (FDA)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2024-Q1 | 2022-01-01 | null | CA | US | 12 | 0 | 1 | 2024-07-26T16:55:00.714723-04:00 | JAZZ PHARMACEUTICALS, INC. | c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US | 401,106,071 | Pharmaceuticals | JENNIE SKELTON | 401,106,071 | +1 415-903-2800 | [
"MARK BOLTON",
"VIRGINIA MCMILLIN",
"KARAS GROSS"
] | [
143458,
100657,
139471
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/210180/ | https://lda.senate.gov/api/v1/registrants/401106071/ | https://lda.senate.gov/filings/public/filing/9ed4bee6-bf9b-49cc-9119-783f7724e0e6/print/ | 9ed4bee6-bf9b-49cc-9119-783f7724e0e6 | 9ed4bee6-bf9b-49cc-9119-783f7724e0e6_401106071_210180 | jazz pharmaceuticals, inc. | 2024-04-19T22:22:04 |
47214710 | 2024-04-22T00:00:00 | jazz pharmaceuticals, inc. | Specialty pharmaceuticals | 50,000 | lobbying_income | service_provided | [
"Issues related to biosecurity",
"Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)",
"Drug safety, prescription drug abuse, value of prescription drugs; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Conso... | [
"DEF - Defense",
"MMM - Medicare/Medicaid",
"HCR - Health Issues"
] | [
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2024-Q1 | 2012-03-01 | null | CA | US | 1,004,164 | 0 | 0 | 2024-07-30T19:14:36.870757-04:00 | AVENUE SOLUTIONS | 401 9th St. NW, Suite 720, Washington, DC, 20004, US | 72,111 | Government representation | AMY TEJRAL | 35,940 | +1 202-347-9848 | [
"TRACY SPICER",
"TRACY SPICER",
"TRACY SPICER"
] | [
23462,
23462,
23462
] | [
null,
null,
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/165792/ | https://lda.senate.gov/api/v1/registrants/72111/ | https://lda.senate.gov/filings/public/filing/cd716564-542e-4fd0-b36b-9162ee2b0e37/print/ | cd716564-542e-4fd0-b36b-9162ee2b0e37 | cd716564-542e-4fd0-b36b-9162ee2b0e37_72111_165792 | jazz pharmaceuticals, inc. | 2024-04-22T20:33:36 |
4755 | 2007-08-07T00:00:00 | medical device manufacturers association | null | 20,000 | lobbying_income | terminate | [
"H.R.3590, Patient Protection and Affordable Care Act, S.301, Physician Payments Sunshine Act of 2009; H.R.3962, America's Affordable Health Choices Act of 2009; S.1679, Affordable Health Choices Act; America's Healthy Future Act of 2009; Issues related to healthcare reform legislation; Issues related to group purc... | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2009-Q4 | 2007-08-07 | 2009-12-31 | DC | US | 3,693 | 0 | 0 | 2024-04-02T09:42:37.694409-04:00 | OGR | 1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US | 48,827 | lobbying firm | RAWSON WARDEN | 34,528 | +1 202-729-4200 | [
"ANDREW ROSENBERG"
] | [
37206
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/155797/ | https://lda.senate.gov/api/v1/registrants/48827/ | https://lda.senate.gov/filings/public/filing/ca0d92ce-02aa-4313-bbaa-55562a68892f/print/ | ca0d92ce-02aa-4313-bbaa-55562a68892f | ca0d92ce-02aa-4313-bbaa-55562a68892f_48827_155797 | medical device manufacturers association | null |
4755 | 2007-08-08T00:00:00 | medical device manufacturers association | null | 15,000 | lobbying_income | service_provided | [
"H.R. 3200--American's Affordable Health Choices Act\nS.1796--America's Healthy Future Act of 2009\nMedical Device Excise Tax"
] | [
"HCR - Health Issues"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2009-Q4 | 2007-08-08 | null | DC | US | 36 | 0 | null | 2024-04-05T13:54:32.459249-04:00 | WALTER CONSULTING | 7111 Capitol View Drive, McLean, VA, 22101, US | 301,697 | Federal health care advocacy | MRS. SARAH WALTER | 37,801 | +1 202-288-8190 | [
"SARAH WALTER (Former Legislative Director, Sen. John Breaux)"
] | [
33110
] | [
"Former Legislative Director, Sen. John Breaux"
] | [
false
] | https://lda.senate.gov/api/v1/clients/180707/ | https://lda.senate.gov/api/v1/registrants/301697/ | https://lda.senate.gov/filings/public/filing/4bdb24cf-f186-41e4-a72f-ef5f61d2d084/print/ | 4bdb24cf-f186-41e4-a72f-ef5f61d2d084 | 4bdb24cf-f186-41e4-a72f-ef5f61d2d084_301697_180707 | medical device manufacturers association | null |
4755 | 2007-08-14T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | retainer | [] | null | null | 2009-Q4 | 2007-08-14 | null | DC | US | 1,038 | 0 | null | 2022-04-06T16:04:30.396745-04:00 | LATHAM & WATKINS LLP | 555 11th Street, NW, Suite 1000, Washington, DC, 20004, US | 22,201 | law firm | EMILY GIBSON | 30,855 | +1 213-892-3210 | null | null | null | null | https://lda.senate.gov/api/v1/clients/129079/ | https://lda.senate.gov/api/v1/registrants/22201/ | https://lda.senate.gov/filings/public/filing/51df5678-a653-4371-96e7-028f41798910/print/ | 51df5678-a653-4371-96e7-028f41798910 | 51df5678-a653-4371-96e7-028f41798910_22201_129079 | medical device manufacturers association | null |
4755 | 2007-08-14T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | retainer | [] | null | null | 2011-Q4 | 2007-08-14 | null | DC | US | 1,038 | 0 | null | 2022-04-06T16:04:30.396745-04:00 | LATHAM & WATKINS LLP | 555 11th Street, NW, Suite 1000, Washington, DC, 20004, US | 22,201 | law firm | EMILY GIBSON | 30,855 | +1 213-892-3210 | null | null | null | null | https://lda.senate.gov/api/v1/clients/129079/ | https://lda.senate.gov/api/v1/registrants/22201/ | https://lda.senate.gov/filings/public/filing/06dc6ebd-821c-431d-b738-9bc19376d5c9/print/ | 06dc6ebd-821c-431d-b738-9bc19376d5c9 | 06dc6ebd-821c-431d-b738-9bc19376d5c9_22201_129079 | medical device manufacturers association | null |
4755 | 2007-08-14T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | retainer | [] | null | null | 2016-Q4 | 2007-08-14 | null | DC | US | 1,038 | 0 | null | 2022-04-06T16:04:30.396745-04:00 | LATHAM & WATKINS LLP | 555 11th Street, NW, Suite 1000, Washington, DC, 20004, US | 22,201 | law firm | EMILY GIBSON | 30,855 | +1 213-892-3210 | null | null | null | null | https://lda.senate.gov/api/v1/clients/129079/ | https://lda.senate.gov/api/v1/registrants/22201/ | https://lda.senate.gov/filings/public/filing/9eabd244-f973-4bcf-ac72-ca4d1e4ea17f/print/ | 9eabd244-f973-4bcf-ac72-ca4d1e4ea17f | 9eabd244-f973-4bcf-ac72-ca4d1e4ea17f_22201_129079 | medical device manufacturers association | null |
4755 | 2008-04-15T00:00:00 | medical device manufacturers association | null | 15,000 | lobbying_income | service_provided | [
"S.2029--Physician Payments Sunshine Act of 2007\nEnsuring patient access to innovative medical technologies"
] | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2008-Q1 | 2007-08-08 | null | DC | US | 36 | 0 | null | 2024-04-05T13:54:32.459249-04:00 | WALTER CONSULTING | 7111 Capitol View Drive, McLean, VA, 22101, US | 301,697 | Federal health care advocacy | MRS. SARAH WALTER | 37,801 | +1 202-288-8190 | [
"SARAH WALTER"
] | [
33110
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/180707/ | https://lda.senate.gov/api/v1/registrants/301697/ | https://lda.senate.gov/filings/public/filing/71312cbd-6016-4f5f-8c36-3e6fbd532690/print/ | 71312cbd-6016-4f5f-8c36-3e6fbd532690 | 71312cbd-6016-4f5f-8c36-3e6fbd532690_301697_180707 | medical device manufacturers association | 2008-04-15T18:55:23 |
4755 | 2008-04-16T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | service_provided | [
"Oversight of the Food and Drug Administration"
] | [
"MED - Medical/Disease Research/Clinical Labs"
] | [
"135 - Food & Drug Administration (FDA)"
] | 2008-Q1 | 2007-08-14 | null | DC | US | 1,038 | 0 | null | 2022-04-06T16:04:30.396745-04:00 | LATHAM & WATKINS LLP | 555 11th Street, NW, Suite 1000, Washington, DC, 20004, US | 22,201 | law firm | EMILY GIBSON | 30,855 | +1 213-892-3210 | [
"JOHN MANTHEI"
] | [
4223
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/129079/ | https://lda.senate.gov/api/v1/registrants/22201/ | https://lda.senate.gov/filings/public/filing/9ba0e580-fc09-4442-aee6-3277ae11b213/print/ | 9ba0e580-fc09-4442-aee6-3277ae11b213 | 9ba0e580-fc09-4442-aee6-3277ae11b213_22201_129079 | medical device manufacturers association | 2008-04-16T18:54:45 |
4755 | 2008-04-17T00:00:00 | medical device manufacturers association | null | 20,000 | lobbying_income | service_provided | [
"S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.\nIssues related to group purchasing organizations' Medicare Safe Harbor."
] | [
"MMM - Medicare/Medicaid"
] | null | 2008-Q1 | 2007-08-07 | null | DC | US | 3,693 | 0 | 0 | 2024-04-02T09:42:37.694409-04:00 | OGR | 1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US | 48,827 | lobbying firm | RAWSON WARDEN | 34,528 | +1 202-729-4200 | [
"ANDREW ROSENBERG",
"JULIE DAMMANN (Chief of Staff, Senator Christopher S. Bond)",
"WAYNE BERMAN"
] | [
37206,
3791,
20506
] | [
null,
"Chief of Staff, Senator Christopher S. Bond",
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/155797/ | https://lda.senate.gov/api/v1/registrants/48827/ | https://lda.senate.gov/filings/public/filing/985372d9-569d-42e9-878c-fe713508515b/print/ | 985372d9-569d-42e9-878c-fe713508515b | 985372d9-569d-42e9-878c-fe713508515b_48827_155797 | medical device manufacturers association | 2008-04-17T14:25:03 |
4755 | 2008-04-19T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | terminate_retainer | [] | null | null | 2008-Q1 | 2007-08-11 | 2008-01-01 | DC | US | 2,171 | 0 | 0 | 2024-01-30T19:20:32.148908-05:00 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 1155 F Street NW, Suite 1200, Washington, DC, 20004, US | 7,257 | Law firm | QUINN MCKAY | 31,842 | +1 202-872-5292 | null | null | null | null | https://lda.senate.gov/api/v1/clients/109842/ | https://lda.senate.gov/api/v1/registrants/7257/ | https://lda.senate.gov/filings/public/filing/8f6921d7-41b0-478d-82de-5c834ae5b4f0/print/ | 8f6921d7-41b0-478d-82de-5c834ae5b4f0 | 8f6921d7-41b0-478d-82de-5c834ae5b4f0_7257_109842 | medical device manufacturers association | 2008-04-19T23:16:46 |
4755 | 2008-04-21T00:00:00 | medical device manufacturers association | null | 70,000 | a | service_provided | [
"Issues Relating to the Patent Reform Act of 2007 (H.R. 1908/ S.1145)",
"Issues relating to Group Purchasing Organizations\nIssues Relating to the Physician Sunshine Act of 2007 (S.2029)\nIssues relating to Transparency in Mecial Device Pricing (S.2221)\nIssues Relating to Comparative Effectiveness",
"Issues re... | [
"CPT - Copyright/Patent/Trademark",
"HCR - Health Issues",
"SMB - Small Business",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"136 - Centers For Medicare and Medicaid Services (CMS)",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"113 - Patent & Trademark Office (PTO)",
"1 - SENATE",
"136 - Centers For Medicare and Medicaid Services (CMS)",
"135 - Foo... | 2008-Q1 | 2014-02-24 | null | DC | US | 12 | 0 | 1 | 2024-01-08T15:44:39.815951-05:00 | MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 1333 H Street NW, Ste 400W, WASHINGTON, DC, 20005, US | 24,794 | trade association | MR. MARK B. LEAHEY | 31,975 | +1 202-354-7171 | [
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI"
] | [
10041,
46992,
10041,
46992,
10041,
46992,
10041,
46992,
10041,
46992
] | [
null,
null,
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/132537/ | https://lda.senate.gov/api/v1/registrants/24794/ | https://lda.senate.gov/filings/public/filing/bcaf3653-a94d-44f5-9471-cd34d965985b/print/ | bcaf3653-a94d-44f5-9471-cd34d965985b | bcaf3653-a94d-44f5-9471-cd34d965985b_24794_132537 | medical device manufacturers association | 2008-04-21T13:30:58 |
4755 | 2008-07-16T00:00:00 | medical device manufacturers association | null | 20,000 | lobbying_income | service_provided | [
"S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.\nIssues related to group purchasing organizations' Medicare Safe Harbor."
] | [
"MMM - Medicare/Medicaid"
] | [
"1 - SENATE"
] | 2008-Q2 | 2007-08-07 | null | DC | US | 3,693 | 0 | 0 | 2024-04-02T09:42:37.694409-04:00 | OGR | 1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US | 48,827 | lobbying firm | RAWSON WARDEN | 34,528 | +1 202-729-4200 | [
"ANDREW ROSENBERG",
"JULIE DAMMANN (Chief of Staff, Senator Christopher S. Bond)",
"WAYNE BERMAN"
] | [
37206,
3791,
20506
] | [
null,
"Chief of Staff, Senator Christopher S. Bond",
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/155797/ | https://lda.senate.gov/api/v1/registrants/48827/ | https://lda.senate.gov/filings/public/filing/3831e406-d17e-4a24-952c-b7b1bb2c5e1c/print/ | 3831e406-d17e-4a24-952c-b7b1bb2c5e1c | 3831e406-d17e-4a24-952c-b7b1bb2c5e1c_48827_155797 | medical device manufacturers association | 2008-07-16T14:31:26 |
4755 | 2008-07-16T00:00:00 | medical device manufacturers association | null | 15,000 | lobbying_income | service_provided | [
"HR 6331-- Medicare Improvements for Patients and Providers Act of 2008\nS.2029-- Physician Payment Sunshine Act of 2007"
] | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2008-Q2 | 2007-08-08 | null | DC | US | 36 | 0 | null | 2024-04-05T13:54:32.459249-04:00 | WALTER CONSULTING | 7111 Capitol View Drive, McLean, VA, 22101, US | 301,697 | Federal health care advocacy | MRS. SARAH WALTER | 37,801 | +1 202-288-8190 | [
"SARAH WALTER"
] | [
33110
] | [
null
] | [
false
] | https://lda.senate.gov/api/v1/clients/180707/ | https://lda.senate.gov/api/v1/registrants/301697/ | https://lda.senate.gov/filings/public/filing/a2265df2-9e78-4ad8-af22-6567b8de740d/print/ | a2265df2-9e78-4ad8-af22-6567b8de740d | a2265df2-9e78-4ad8-af22-6567b8de740d_301697_180707 | medical device manufacturers association | 2008-07-16T18:25:34 |
4755 | 2008-07-17T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | retainer | [] | null | null | 2008-Q2 | 2007-08-14 | null | DC | US | 1,038 | 0 | null | 2022-04-06T16:04:30.396745-04:00 | LATHAM & WATKINS LLP | 555 11th Street, NW, Suite 1000, Washington, DC, 20004, US | 22,201 | law firm | EMILY GIBSON | 30,855 | +1 213-892-3210 | null | null | null | null | https://lda.senate.gov/api/v1/clients/129079/ | https://lda.senate.gov/api/v1/registrants/22201/ | https://lda.senate.gov/filings/public/filing/b4a2faa7-ee55-4fdc-b648-616e4ad3a141/print/ | b4a2faa7-ee55-4fdc-b648-616e4ad3a141 | b4a2faa7-ee55-4fdc-b648-616e4ad3a141_22201_129079 | medical device manufacturers association | 2008-07-17T14:39:08 |
4755 | 2008-07-17T00:00:00 | medical device manufacturers association | null | 70,000 | a | service_provided | [
"Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to The Physician Sunshine Act (s.2029), Issues relating to Transparency in Medical Device Pricing Act of 2007 (S.2221), Issues relating to Comparative Effectiveness, Issues relating ... | [
"HCR - Health Issues",
"CPT - Copyright/Patent/Trademark",
"MMM - Medicare/Medicaid",
"BUD - Budget/Appropriations"
] | [
"136 - Centers For Medicare and Medicaid Services (CMS)",
"135 - Food & Drug Administration (FDA)",
"34 - Health & Human Services, Dept of (HHS)",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"136 - Centers For Medicare and Medicaid Services (CMS)",
"135 - Food & Drug Administration (FDA)",
"34 - Hea... | 2008-Q2 | 2014-02-24 | null | DC | US | 12 | 0 | 1 | 2024-01-08T15:44:39.815951-05:00 | MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 1333 H Street NW, Ste 400W, WASHINGTON, DC, 20005, US | 24,794 | trade association | MR. MARK B. LEAHEY | 31,975 | +1 202-354-7171 | [
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI",
"MARK LEAHEY",
"THOMAS C NOVELLI"
] | [
10041,
46992,
10041,
46992,
10041,
46992,
10041,
46992
] | [
null,
null,
null,
null,
null,
null,
null,
null
] | [
false,
false,
false,
false,
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/132537/ | https://lda.senate.gov/api/v1/registrants/24794/ | https://lda.senate.gov/filings/public/filing/089c572a-348b-489e-9e4b-23f190072144/print/ | 089c572a-348b-489e-9e4b-23f190072144 | 089c572a-348b-489e-9e4b-23f190072144_24794_132537 | medical device manufacturers association | 2008-07-17T15:01:20 |
4755 | 2008-09-01T00:00:00 | medical device manufacturers association | Trade association for medical device manufacturers | 20,000 | lobbying_income | service_provided | [
"Opposition to medical device industry tax in H.R. 3962, \"Affordable Health Care for America Act,\" and H.R. 3590, \"Patient Protection and Affordable Care Act.\""
] | [
"TAX - Taxation/Internal Revenue Code"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2009-Q4 | 2008-09-01 | null | DC | US | 303 | 0 | 0 | 2024-01-31T11:02:48.049026-05:00 | THE MCMANUS GROUP | 610 10th St. NW, Suite 300, Washington, DC, 20001, US | 286,096 | Consulting | NATE GASPAR | 36,969 | +1 434-989-7548 | [
"JOHN MCMANUS",
"NICK SHIPLEY (Legislative Director, Rep. Jay Inslee)"
] | [
9573,
47494
] | [
null,
"Legislative Director, Rep. Jay Inslee"
] | [
false,
false
] | https://lda.senate.gov/api/v1/clients/176447/ | https://lda.senate.gov/api/v1/registrants/286096/ | https://lda.senate.gov/filings/public/filing/2d800f1e-c358-4ac8-b9a8-198f0801d4d5/print/ | 2d800f1e-c358-4ac8-b9a8-198f0801d4d5 | 2d800f1e-c358-4ac8-b9a8-198f0801d4d5_286096_176447 | medical device manufacturers association | null |
4755 | 2008-09-01T00:00:00 | medical device manufacturers association | Trade association for medical device manufacturers | 30,000 | lobbying_income | service_provided | [
"FDA approval issues.",
"Support for H.R. 436 \"Protect Medical Innovation Act,\" S. 17 \"Medical Device Access and Innovation Protection Act,\" and S. 262 \"A bill to repeal the excise tax on medical device manufacturers.\""
] | [
"HCR - Health Issues",
"TAX - Taxation/Internal Revenue Code"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2011-Q4 | 2008-09-01 | null | DC | US | 303 | 0 | 0 | 2024-01-31T11:02:48.049026-05:00 | THE MCMANUS GROUP | 610 10th St. NW, Suite 300, Washington, DC, 20001, US | 286,096 | Consulting | NATE GASPAR | 36,969 | +1 434-989-7548 | [
"JOHN MCMANUS",
"NICK SHIPLEY (Legislative Director, Rep. Jay Inslee)",
"JOHN MCMANUS",
"NICK SHIPLEY (Legislative Director, Rep. Jay Inslee)"
] | [
9573,
47494,
9573,
47494
] | [
null,
"Legislative Director, Rep. Jay Inslee",
null,
"Legislative Director, Rep. Jay Inslee"
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/176447/ | https://lda.senate.gov/api/v1/registrants/286096/ | https://lda.senate.gov/filings/public/filing/96b388a3-5fa1-44ec-b46c-1e0c5e6c081e/print/ | 96b388a3-5fa1-44ec-b46c-1e0c5e6c081e | 96b388a3-5fa1-44ec-b46c-1e0c5e6c081e_286096_176447 | medical device manufacturers association | null |
4755 | 2008-09-01T00:00:00 | medical device manufacturers association | Trade association for medical device manufacturers | 30,000 | lobbying_income | service_provided | [
"H.R.160 - Protect Medical Innovation Act of 2015 & S.149 - Medical Device Access and Innovation Protection Act",
"Issues related to market access."
] | [
"TAX - Taxation/Internal Revenue Code",
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE",
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2016-Q4 | 2008-09-01 | null | DC | US | 303 | 0 | 0 | 2024-01-31T11:02:48.049026-05:00 | THE MCMANUS GROUP | 610 10th St. NW, Suite 300, Washington, DC, 20001, US | 286,096 | Consulting | NATE GASPAR | 36,969 | +1 434-989-7548 | [
"JOHN MCMANUS",
"BARRETT THORNHILL",
"JOHN MCMANUS",
"BARRETT THORNHILL"
] | [
9573,
59333,
9573,
59333
] | [
null,
null,
null,
null
] | [
false,
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/176447/ | https://lda.senate.gov/api/v1/registrants/286096/ | https://lda.senate.gov/filings/public/filing/cfd12047-3d70-410c-9c4b-3269c8730a9f/print/ | cfd12047-3d70-410c-9c4b-3269c8730a9f | cfd12047-3d70-410c-9c4b-3269c8730a9f_286096_176447 | medical device manufacturers association | null |
4755 | 2008-09-01T00:00:00 | medical device manufacturers association | Trade association for medical device manufacturers | 30,000 | lobbying_income | modify_service | [
"Support for S. 692 - Protection Medical Innovation Act of 2019. Support for H.R. 2207 - To amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices."
] | [
"TAX - Taxation/Internal Revenue Code"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2019-Q1 | 2008-09-01 | null | DC | US | 303 | 0 | 0 | 2024-01-31T11:02:48.049026-05:00 | THE MCMANUS GROUP | 610 10th St. NW, Suite 300, Washington, DC, 20001, US | 286,096 | Consulting | NATE GASPAR | 36,969 | +1 434-989-7548 | [
"JOHN MCMANUS",
"BARRETT THORNHILL",
"WILLIAM RHYNE"
] | [
9573,
59333,
70433
] | [
null,
null,
null
] | [
false,
false,
true
] | https://lda.senate.gov/api/v1/clients/176447/ | https://lda.senate.gov/api/v1/registrants/286096/ | https://lda.senate.gov/filings/public/filing/96590caf-35d3-4a58-b097-442d825e624d/print/ | 96590caf-35d3-4a58-b097-442d825e624d | 96590caf-35d3-4a58-b097-442d825e624d_286096_176447 | medical device manufacturers association | null |
4755 | 2008-10-10T00:00:00 | medical device manufacturers association | null | 5,000 | lobbying_income | retainer | [] | null | null | 2008-Q3 | 2007-08-14 | null | DC | US | 1,038 | 0 | null | 2022-04-06T16:04:30.396745-04:00 | LATHAM & WATKINS LLP | 555 11th Street, NW, Suite 1000, Washington, DC, 20004, US | 22,201 | law firm | EMILY GIBSON | 30,855 | +1 213-892-3210 | null | null | null | null | https://lda.senate.gov/api/v1/clients/129079/ | https://lda.senate.gov/api/v1/registrants/22201/ | https://lda.senate.gov/filings/public/filing/acc21243-9e24-4bb3-ac90-01ac4485413a/print/ | acc21243-9e24-4bb3-ac90-01ac4485413a | acc21243-9e24-4bb3-ac90-01ac4485413a_22201_129079 | medical device manufacturers association | 2008-10-10T20:27:21 |
4755 | 2008-10-16T00:00:00 | medical device manufacturers association | null | 20,000 | lobbying_income | service_provided | [
"S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.\nS.2029, Physician Payments Sunshine Act of 2007. \nIssues related to group purchasing organizations' Medicare Safe Harbor."
] | [
"MMM - Medicare/Medicaid"
] | [
"2 - HOUSE OF REPRESENTATIVES",
"1 - SENATE"
] | 2008-Q3 | 2007-08-07 | null | DC | US | 3,693 | 0 | 0 | 2024-04-02T09:42:37.694409-04:00 | OGR | 1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US | 48,827 | lobbying firm | RAWSON WARDEN | 34,528 | +1 202-729-4200 | [
"ANDREW ROSENBERG",
"JULIE DAMMANN (Chief of Staff, Senator Christopher S. Bond)",
"WAYNE BERMAN"
] | [
37206,
3791,
20506
] | [
null,
"Chief of Staff, Senator Christopher S. Bond",
null
] | [
false,
false,
false
] | https://lda.senate.gov/api/v1/clients/155797/ | https://lda.senate.gov/api/v1/registrants/48827/ | https://lda.senate.gov/filings/public/filing/d04709e3-8cc0-4478-b14f-7ac1f7c39bee/print/ | d04709e3-8cc0-4478-b14f-7ac1f7c39bee | d04709e3-8cc0-4478-b14f-7ac1f7c39bee_48827_155797 | medical device manufacturers association | 2008-10-16T17:50:46 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.